Boost for Ireland as Sanofi Invests in Lantus Production
Genzyme says it will produce the insulin drug Lantus for Sanofi following a second investment in its Irish facility.
Archives for February 13, 2013
BMS Manufactures for Now as Reckitt Benckiser Enters Latin America
Bristol-Myers Squibb (B-MS) will continue to make the OTCs it licensed to Reckitt Benckiser for the time being but will hand over manufacturing if the UK drugmaker buys them outright.
Lantheus: 'Supplier Diversification' Strategy After Ben Venue Shutdown
The US FDA has expedited approval of Jubilant HollisterStier manufacturing sites in further fallout from Ben Venue’s consent decree.
FDA Reveals More Info on API File Submissions
Drug Master File (DMF) completeness reviews required under GDUFA could take three months and should be sought before ANDA submission according to the US Food and Drug Administration (FDA).
Outsourcing, Partners Necessary to Make Inroads in China for Small Biotech, Experts Say
Small biotech companies looking to crack into the increasingly lucrative Chinese pharma market need to outsource or partner with a local company in order to bring their products to market faster, experts said.
EpiVax says Novozymes Collaboration has $3bn Potential
EpiVax says combining its immune 'off switch’ drugs with Novozymes’ half-life boosting Albufuse platform could deliver a $3bn (€2.2bn) section of the autoimmune disease market.